Country: Аустралија
Језик: Енглески
Извор: APVMA (Australian Pesticides and Veterinary Medicines Authority)
MELOXICAM
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
meloxicam(15mg/mL)
ORAL SOLUTION/SUSPENSION
MELOXICAM UNGROUPED Active 15.0 mg/ml
100mL; 250mL
VM - Veterinary Medicine
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
MUSCULOSKELETAL SYSTEM
COLIC | MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE
Poison schedule: 4; Withholding period: MEAT WHP (HORSES): DO NOT USE less tha n 28 days before slaughter for human co nsumption.; Host/pest details: HORSE: [COLIC, MUSCULOSKELETAL CONDITIONS]; For the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders.Contraindicated for use in pregnant or lactating mares as no data has been established also in horses less than 6 weeks of age. Refer to product leaflet also.
Registered
2023-07-01
METACAM 15 MG/ML ORAL SUSPENSION FOR HORSES 63170/135205 Product Name: APVMA Approval No: Label Name: METACAM 15 MG/ML ORAL SUSPENSION FOR HORSES Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS Constituent Statements: 15 mg/mL MELOXICAM Claims: Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses. Net Contents: 100 mL 250 mL Directions for Use: Restraints: Contraindications: Contraindicated for use in pregnant or lactating mares. Contraindicated for use in horses less than 6 weeks of age. The use of the product is contraindicated in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of individual hypersensitivity to the product. Contraindicated for concurrent administration with glucocorticoids or other non-steroidal anti-inflammatory drugs, or with anti-coagulant agents. Precautions: Avoid use in any dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk of renal toxicity. RLP APPROVED Side Effects: In clinical trials some side effects consistent with the use of Non-Steroidal Anti- Inflammatory Drugs (NSAIDs) were observed such as slight urticaria and diarrhoea. Symptoms were reversible. In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported. In very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically. If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. In case of overdosing a symptomatic treatment should be initiated. Dosage and Administration: Use the contents within 6 months of first broaching the container. Discard the unused portion. Shake well before use. To be administered at a dosage of 0.6 mg/kg bodyweight, once daily, up to 14 days. To be administered ei Прочитајте комплетан документ
CS: 1.7.2 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ1IC September 2012 ISSUED by BOEHRING Issue Date : METACAM® 15MG/ML ORAL SUSPENSION FOR HORSES Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER METACAM® 15mg/mL ORAL SUSPENSION FOR HORSES PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders. RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Hazard classification according to the criteria of NOHSC. Dangerous goods classification according to the Australia Dangerous Goods Code. HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS Each mL contains 15 mg Meloxicam. COMPOSITION, INFORMATION ON INGREDIENTS NAME CAS PROPORTION INGREDIENTS Ingredients determined not to be hazardous Balance Meloxicam (4-hydroxy-2-methyl-N- (5-methyl-2-thiazolyl)- 2H-1,2-benzothiazine-3- carboxamide-1,1-dioxide ) 71125-38-7 15 mg/mL 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mouth thoroughly with water. If symptoms develop seek medical attention. INGESTION Wash affected area thoroughly with soap and water. If symptoms develop seek medical attention. Contact a physician immediately and show the packet insert or label to the physician. SKIN If in eyes, hold eyelids apart and flush the eyes continuously with running water. Continue flushing for several minutes until all contaminants are washed out completely. If symptoms develop and persist seek medical attention. EYE Eyewash and normal washroom facilities. FIRST AID FACILITI Прочитајте комплетан документ